Saltar al contenido
Merck

A dopamine-induced gene expression signature regulates neuronal function and cocaine response.

Science advances (2020-07-09)
Katherine E Savell, Jennifer J Tuscher, Morgan E Zipperly, Corey G Duke, Robert A Phillips, Allison J Bauman, Saakshi Thukral, Faraz A Sultan, Nicholas A Goska, Lara Ianov, Jeremy J Day
RESUMEN

Drugs of abuse elevate dopamine levels in the nucleus accumbens (NAc) and alter transcriptional programs believed to promote long-lasting synaptic and behavioral adaptations. Here, we leveraged single-nucleus RNA-sequencing to generate a comprehensive molecular atlas of cell subtypes in the NAc, defining both sex-specific and cell type-specific responses to acute cocaine experience in a rat model system. Using this transcriptional map, we identified an immediate early gene expression program that is up-regulated following cocaine experience in vivo and dopamine receptor activation in vitro. Multiplexed induction of this gene program with a large-scale CRISPR-dCas9 activation strategy initiated a secondary synapse-centric transcriptional profile, altered striatal physiology in vitro, and enhanced cocaine sensitization in vivo. Together, these results define the transcriptional response to cocaine with cellular precision and demonstrate that drug-responsive gene programs can potentiate both physiological and behavioral adaptations to drugs of abuse.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Dopamina hydrochloride
Sigma-Aldrich
7-Aminoactinomycin D, ~97% (HPLC), powder
Sigma-Aldrich
U0126, U0126, CAS 109511-58-2, is a potent and specific inhibitor of MEK1 (IC₅₀ = 72 nM) and MEK2 (IC₅₀ = 58 nM). The inhibition is noncompetitive with respect to both ATP and ERK.
Sigma-Aldrich
Cocaine free base
Sigma-Aldrich
R(+)-SCH-23390 hydrochloride, ≥98% (HPLC), solid
Sigma-Aldrich
U0124, A useful negative control for MEK inhibitors U0125 and U0126.